• 2488 Citations
  • 14 h-Index
1988 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 1 Similar Profiles
Breast Neoplasms Medicine & Life Sciences
zoledronic acid Medicine & Life Sciences
letrozole Medicine & Life Sciences
erbB-2 Genes Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Gene Amplification Medicine & Life Sciences
Triple Negative Breast Neoplasms Medicine & Life Sciences
Circulating Neoplastic Cells Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1988 2019

  • 2488 Citations
  • 14 h-Index
  • 30 Article
  • 1 Chapter
1 Citations
T-Lymphocytes
Antibodies
Neoplasms
Colonic Neoplasms
Colorectal Neoplasms

Isolated Contralateral Axillary Lymph Node Involvement in Breast Cancer Represents a Locally Advanced Disease Not Distant Metastases

Chkheidze, R., Sanders, M. A. G., Haley, B. B., Leitch, A. M. & Sahoo, S., Jan 1 2018, (Accepted/In press) In : Clinical Breast Cancer.

Research output: Contribution to journalArticle

Lymph Nodes
Breast Neoplasms
Neoplasm Metastasis
Simple Mastectomy
Axilla
10 Citations

Randomized phase II trial of fulvestrant plus everolimus or placebo in postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer resistant to aromatase inhibitor therapy: Results of PrE0102

Kornblum, N., Zhao, F., Manola, J., Klein, P., Ramaswamy, B., Brufsky, A., Stella, P. J., Burnette, B., Telli, M., Makower, D. F., Cheema, P., Truica, C. I., Wolff, A. C., Soori, G. S., Haley, B. B., Wassenaar, T. R., Goldstein, L. J., Miller, K. D. & Sparano, J. A., Jun 1 2018, In : Journal of Clinical Oncology. 36, 16, p. 1556-1563 8 p.

Research output: Contribution to journalArticle

Aromatase Inhibitors
Placebos
Hormones
Breast Neoplasms
Estrogen Receptors
9 Citations

Recurrent hyperactive ESR1 fusion proteins in endocrine therapy-resistant breast cancer

Hartmaier, R. J., Trabucco, S. E., Priedigkeit, N., Chung, J. H., Parachoniak, C. A., Vanden Borre, P., Morley, S., Rosenzweig, M., Gay, L. M., Goldberg, M. E., Suh, J., Ali, S. M., Ross, J., Leyland-Jones, B., Young, B., Williams, C., Park, B., Tsai, M., Haley, B. B., Peguero, J. & 19 othersCallahan, R. D., Sachelarie, I., Cho, J., Atkinson, J. M., Bahreini, A., Nagle, A. M., Puhalla, S. L., Watters, R. J., Erdogan-Yildirim, Z., Cao, L., Oesterreich, S., Mathew, A., Lucas, P. C., Davidson, N. E., Brufsky, A. M., Frampton, G. M., Stephens, P. J., Chmielecki, J. & Lee, A. V., Apr 1 2018, In : Annals of Oncology. 29, 4, p. 872-880 9 p.

Research output: Contribution to journalArticle

Breast Neoplasms
Neoplasm Genes
Gene Fusion
Ligands
Proteins
Breast Neoplasms
Neoplasms
Architectural Accessibility
Counseling
Guidelines